Latest NF-κB Stories
Ubiquitin system produces a protein that greatly restricts the development of cancerous tumors NEW YORK, April 10, 2015 /PRNewswire-USNewswire/ -- A new study by researchers at the
A new “trick” steroids use to suppress inflammation, which could be used to make new anti-inflammatory drugs without the harmful side effects of steroids, has been discovered by researchers
-- Permits quantitative, statistically robust assessment of NFkB translocation DARMSTADT, Germany, Nov.
SARASOTA, Fla., Nov.
New Assay Critical to the Study of the Human Immune Responses and Cancers. State College, PA (PRWEB) October 17, 2014 INDIGO Biosciences, a leading provider
A new study led by scientists at the University of Pennsylvania School of Veterinary Medicine has painted a clearer picture of the delicate arms race between the human immune system and a pathogen that seeks to infect and kill human cells.
CAMBRIDGE, Mass., March 14, 2014 /PRNewswire/ -- Catabasis Pharmaceuticals Inc. today announced that data from its Phase 1 clinical
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified the most common genetic alteration ever reported in the brain tumor ependymoma and evidence that the alteration drives tumor development.
A gene long presumed dead comes to life under the full moon of inflammation.